These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 17951225)

  • 1. Outcomes research in cancer symptom management trials: the Radiation Therapy Oncology Group (RTOG) conceptual model.
    Bruner DW
    J Natl Cancer Inst Monogr; 2007; (37):12-5. PubMed ID: 17951225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health-related quality of life measurement in symptom management trials.
    Ganz PA; Goodwin PJ
    J Natl Cancer Inst Monogr; 2007; (37):47-52. PubMed ID: 17951231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of patient-reported outcomes in clinical trials: the example of health-related quality of life.
    Wiklund I
    Fundam Clin Pharmacol; 2004 Jun; 18(3):351-63. PubMed ID: 15147288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Standardizing patient-reported outcomes assessment in cancer clinical trials: a patient-reported outcomes measurement information system initiative.
    Garcia SF; Cella D; Clauser SB; Flynn KE; Lad T; Lai JS; Reeve BB; Smith AW; Stone AA; Weinfurt K
    J Clin Oncol; 2007 Nov; 25(32):5106-12. PubMed ID: 17991929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measuring treatment impact: a review of patient-reported outcomes and other efficacy endpoints in approved product labels.
    Willke RJ; Burke LB; Erickson P
    Control Clin Trials; 2004 Dec; 25(6):535-52. PubMed ID: 15588741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic significance of patient-reported outcomes in cancer clinical trials.
    Gotay CC; Kawamoto CT; Bottomley A; Efficace F
    J Clin Oncol; 2008 Mar; 26(8):1355-63. PubMed ID: 18227528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Translating the science of patient-reported outcomes assessment into clinical practice.
    Osoba D
    J Natl Cancer Inst Monogr; 2007; (37):5-11. PubMed ID: 17951224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality-of-life assessment in the symptom management trials of the National Cancer Institute-supported Community Clinical Oncology Program.
    Buchanan DR; O'Mara AM; Kelaghan JW; Minasian LM
    J Clin Oncol; 2005 Jan; 23(3):591-8. PubMed ID: 15659506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of life in oncology trials: a clinical guide.
    Movsas B
    Semin Radiat Oncol; 2003 Jul; 13(3):235-47. PubMed ID: 12903013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should health-related quality of life be measured in cancer symptom management clinical trials? Lessons learned using the functional assessment of cancer therapy.
    Cella D; Wagner L; Cashy J; Hensing TA; Yount S; Lilenbaum RC
    J Natl Cancer Inst Monogr; 2007; (37):53-60. PubMed ID: 17951232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in what quality-of-life instruments measure.
    Ferrans CE
    J Natl Cancer Inst Monogr; 2007; (37):22-6. PubMed ID: 17951227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrating patient-reported outcomes into cancer symptom management clinical trials supported by the National Cancer Institute-sponsored clinical trials networks.
    Sloan JA; Berk L; Roscoe J; Fisch MJ; Shaw EG; Wyatt G; Morrow GR; Dueck AC;
    J Clin Oncol; 2007 Nov; 25(32):5070-7. PubMed ID: 17991923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes research in cancer clinical trial cooperative groups: the RTOG model.
    Bruner DW; Movsas B; Konski A; Roach M; Bondy M; Scarintino C; Scott C; Curran W
    Qual Life Res; 2004 Aug; 13(6):1025-41. PubMed ID: 15287270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measuring patient-oriented outcomes in palliative care: functionality and quality of life.
    Granda-Cameron C; Viola SR; Lynch MP; Polomano RC
    Clin J Oncol Nurs; 2008 Feb; 12(1):65-77. PubMed ID: 18258576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality-of-life outcomes in oncology.
    Siddiqui F; Kachnic LA; Movsas B
    Hematol Oncol Clin North Am; 2006 Feb; 20(1):165-85. PubMed ID: 16580562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing health related quality of life in medicine. An overview over concepts, methods and applications in international research.
    Bullinger M
    Restor Neurol Neurosci; 2002; 20(3-4):93-101. PubMed ID: 12454358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient-reported outcomes in cancer: a review of recent research and policy initiatives.
    Lipscomb J; Gotay CC; Snyder CF
    CA Cancer J Clin; 2007; 57(5):278-300. PubMed ID: 17855485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symptom burden: multiple symptoms and their impact as patient-reported outcomes.
    Cleeland CS
    J Natl Cancer Inst Monogr; 2007; (37):16-21. PubMed ID: 17951226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current status of patient-reported outcomes in industry-sponsored oncology clinical trials and product labels.
    Gondek K; Sagnier PP; Gilchrist K; Woolley JM
    J Clin Oncol; 2007 Nov; 25(32):5087-93. PubMed ID: 17991926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conceptual issues in symptom clusters research and their implications for quality-of-life assessment in patients with cancer.
    Miaskowski C; Aouizerat BE; Dodd M; Cooper B
    J Natl Cancer Inst Monogr; 2007; (37):39-46. PubMed ID: 17951230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.